Nimodipine neuroprotection in cardiac valve replacement: Report of an early terminated trial

Stroke

Volumn 27, Issue 4, 1996, Pages 593-598

  Legault, Claudine ^a   Furberg, Curt D ^a   Wagenknecht, Lynne E ^a   Rogers, Anne T ^a   Stump, David A ^a   Coker, Laura ^a   Troost, B Todd ^a   Hammon, John W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

calcium channel blockers; complications; hemorrhage; nimodipine

Indexed keywords

AMINOCAPROIC ACID; NIMODIPINE;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART VALVE REPLACEMENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029867794     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.4.593     Document Type: Article

References (32)

1. Breuer AC, Furlan AJ, Hanson MR, Lederman RL, Loop FD, Cosgrove DM, Greenstreet RL, Estafanous FG. Central nervous system complications of coronary artery bypass graft surgery: prospective analysis of 421 patients. Stroke. 1983;14:682-687.
2. Hammeke TA, Hastings JE. Neuropsychologic alterations after cardiac operation. J Thorac Cardiovasc Surg. 1988;96:326-331.
3. Gardner TJ, Horneffer PJ, Manolio TA. Stroke following coronary artery bypass grafting: a ten year study. Ann Thorac Surg. 1985;40: 574-581.
4. National Cardiac Surgery Database. Second Annual Report. Chicago, Ill: Society of Thoracic Surgeons; January 1993.
5. Newman S, Klinger L, Venn G, Smith P, Harrison M, Treasure T. The persistence of neuropsychological deficits twelve months after coronary artery bypass surgery. In: Willner AE, Rodewald G, eds. Impact of Cardiac Surgery on the Quality of Life. New York, NY: Plenum Publishing Corp; 1990:173-179.
6. Newman S. The incidence and nature of neuropsychological morbidity following cardiac surgery. Perfusion. 1989;4:93-100.
7. Blauth CI, Arnold JV, Schulenberg WE, McCartney AC, Taylor KM. Cerebral microembolism during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1988;95:668-676.
8. Moody DM, Bell MA, Challa VR, Johnson WE, Prough DS. Brain microemboli during cardiac surgery or aortography. Ann Neurol. 1990;28:477-486.
9. Wadworth AN, McTavish D. Nimodipine: a review of its pharmacological properties, and therapeutic efficacy in cerebral disorders. Drugs Aging. 1992;2:262-286.
10. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Rberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
11. Harrison MJG, Schneidau A, Ho R, Smith PLC, Newman S, Treasure T. Cerebrovascular disease and functional outcome after coronary artery bypass surgery. Stroke. 1989;20:235-237.
12. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-276.
13. Grant I, Prigatano GP, Heaton RK, McSweeny AJ, Wright EC, Adams KM. Progressive neuropsychologic impairment and hypoxemia: relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry. 1987;44:999-1006.
14. Reitan RM, Davidson LA. Clinical Neuropsychology: Current Status and Applications. New York, NY: Winston/Wiley; 1974.
15. Diller L, Ben-Yishay Y, Gerstman LJ, Goodkin W, Weinberg J. Studies in Cognition and Rehabilitation in Hemiplegia. New York, NY: New York University Medical Center Institute of Rehabilitation Medicine; 1974. Rehabilitation Monograph 50.
16. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood. 1990;76:1680-1697.
17. Wagenknecht LE, Furberg CD, Hammon JW, Legault C, Troost BT. Surgical bleeding: an unexpected effect of a calcium antagonist. BMJ. 1995;310:776-777.
18. Gore JM, Sloan M, Price TR, Randall AMY, Bovill E, Collen D, and the TIMI Investigators. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction study: Thrombolysis in Myocardial Infarction, phase II, pilot and clinical trial. Circulation. 1991;83:448-459.
19. Becker RC, Caputo R, Ball S, Corrao JM, Baker S, Gore JM. Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administration. Am Heart J. 1993; 126:11-14.
20. Takahara K, Kuroiwa A, Matsushima T, Nakashima Y, Takasugi M. Effects of nifedipine on platelet function. Am Heart J. 1985;109:4-8.
21. Greer IA, Walker JJ, McLaren M. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in vitro. Thromb Res. 1986;41:509-518.
22. Jones CR, Pasanisi F, Elliott HL, Reid JL. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. Br J Clin Pharmacol. 1985;20:191-196.
23. Kiyomoto A, Sasaki Y, Odawara A, Morita T. Inhibition of platelet aggregation by diltiazem. Circ Res. 1983;52(suppl I):115-119.
24. Davi G, Noso S, Fiore M. Effects by nifedipine on thromboxane synthesis in vitro and in vivo. Thromb Res. 1982;28:837-842.
25. Jeremy JY, Barradas MA, Mikhailidis DP, Dandona P. An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis. Drugs Exp Clin Res. 1985;9:645-651.
26. Ring M, Corrigan JJ, Fenster PE. Effects of oral diltiazem on platelet function: alone and in combination with 'low dose' aspirin. Thromb Res. 1986;44:391-400.
27. Epstein PM, Fiss K, Hachisu R, Andrenyak DM. Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin. Biochem Biophys Res Commun. 1982;105:1142-1149.
28. 2+ channel blockade. J Cell Physiol. 1987;132:178-182.
29. Moore JB, Fuller BL, Falotico R, Tolman EL. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers. Thromb Res. 1985;40:401-411.
30. Akopov SE, Sarkisian MA. Antiplatelet effect of nifedipine depending on its action on red cell deformability in essential hypertension. Am J Ther. 1995;2:10-14.
31. Pumphrey CW, Fuster V, Dewanjee MK, Chesebro JH, Vlietstra RE, Kaye MP. Comparison of the antithrombotic action of calcium antagonist drugs with dipyridamole in dogs. Am J Cardiol. 1983;51: 591-595.
32. Feinberg WM, Bruck DC. Effect of oral nimodipine on platelet function. Stroke. 1993;24:10-13.